VerifiedBiotechnology Research· Founded 2015

Alx Oncology

ALX Oncology (Nasdaq: ALXO) is a clinical-stage biotechnology company advancing therapies that boost the immune system to treat cancer and extend patients’ lives. ALX Oncology’s lead therapeutic candidate, evorpacept, has demonstrated potential to serve as a cornerstone therapy upon which the future of immuno-oncology can be built. Evorpacept is currently being evaluated across multiple ongoing clinical trials in a wide range of cancer indications.

7-day free trial · no credit card

South San Francisco, United States65(51 to 200)$1M to <$10M2015alxoncology.com LinkedIn

Verified contacts

53

available on Kipplo

LinkedIn employees

65

51 to 200 range

Open roles

—

no listings

Distinct roles

21

indexed titles

Tech stack

0

tools in use

Monthly traffic

—

organic / mo

Sign up free to see all 53 verified contacts at Alx Oncology

Free for 7 days · 50 credits · no card · only pay for verified records.

Decision-makers and verified team members

53 contacts with verified email or phone · masked until revealed.

Sign up free →

Showing 9 of 53 verified contacts

Top roles at Alx Oncology

21 distinct titles indexed · top 10 shown.

2executive assistant office manager
2executive director, sr associate general counsel
1()
1accountant
1alp mgr
1alx oncology's vp protein sciences
1application developer
1associate scientist
1associate scientist in vivo operations manager, discovery biology
1clinical trial manager
+11more titles

Sign up to unlock all 53 contacts at Alx Oncology

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up to reveal 53 verified contacts at Alx Oncology

7-day trial · no credit card · cancel anytime · only pay for verified records.

Sign up free See pricing

Trusted by sales, marketing, and GTM engineering teams.

Alx Oncology | Kipplo Discover